Substituted propane-phosphonous acid compounds

ABSTRACT

The compounds of the formula    &lt;IMAGE&gt;  I  in which one of the groups R1, R2 and R3 represents hydrogen, C1-8-alkyl, C3-6-cycloalkyl, phenyl optionally substituted by halogeno, C1-4-alkyl, C1-4-alkoxy and/or trifluoromethyl, or C7-10-phenylalkyl optionally substituted in the phenyl moiety by halogeno, C1-4-alkyl, C1-4-alkoxy and/or trifluormethyl, and the other two are hydrogen, or salts thereof. These compounds have valuable pharmaceutical properties.

This application is a continuation of Ser. No. 07/646,586 filed Jan. 25,1992 now abandoned which is a divisional of Ser. No. 07/444,466 filedDec. 1, 1989, issued as U.S. Pat. No. 5,004,826; which is a divisionalof Ser. No. 07/203, 851 filed Jun. 7, 1988, issued as U.S. Pat. No.4,908,465; which is a divisional of Ser. No. 06/940,836 filed Dec. 12,1986, issued as U.S. Pat. No. 4,772,738; which is a divisional of Ser.No. 06/787,300 filed Oct. 15, 1985, issued as U.S. Pat. No. 4,656,298.

The present invention relates to new 3-aminopropanephosphonous acids,processes for their production and their use as pharmaceuticals.

The present invention provides compounds of the formula I, ##STR2## inwhich one of the groups R¹, R² and R³ represents hydrogen, C₁ -₈ -alkyl,C₃ -₆ -cycloalkyl, phenyl optionally substituted by halogeno, C₁ -₄-alkyl, C₁ -₄ -alkoxy and/or trifluoromethyl, or C₇ -₁₀ -phenylalkyloptionally substituted in the phenyl moiety by halogeno, C₁ -₄ -alkyl,C₁ -₄ -alkoxy and/or trifluoromethyl, and the other two are hydrogen; aswell as salts thereof.

A phenyl group may have one or more than one, preferably at most two ofthe same or different substituents.

Alkyl may be e.g. methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl(2-methylpropyl) or t-butyl, as well as n-pentyl, n-hexyl, n-heptyl orn-octyl.

Cycloalkyl may be e.g. cyclopropyl, cyclobutyl or cyclopentyl but ispreferably cyclohexyl.

Alkoxy may be e.g. methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy,sec-butoxy or t-butoxy.

Halogeno is preferably fluoro or chloro, as well as bromo.

Phenylalkyl groups are e.g. benzyl, 1- or 2-phenylethyl, 2- or3-phenylpropyl or 4-phenylbutyl groups, each optionally substituted inthe phenyl portion as described hereinbefore.

Salts of the compounds of the formula I are particularlypharmaceutically acceptable salts thereof, such as the correspondingaddition salts with acids, as well as the salts with bases. Suitableacids for the formation of acid addition salts are, for example, mineralacids, such as hydrochloric, hydrobromic, sulphuric or phosphoric acid,or organic acids, such as organic sulphonic acids, for example,benzenesulphonic, 4-toluenesulphonic or methanesulphonic acid, andorganic carboxylic acids, such as acetic, lactic, palmitic, stearic,malic, maleic, fumaric, tartaric, ascorbic or citric acid. Salts withbases are, for example, alkali metal or alkaline earth metal salts, suchas sodium, potassium, calcium or magnesium salts, or ammonium salts,such as those with ammonia or suitable organic amines, e.g.diethylamine, di-(2-hydroxyethyl)-amine or tri-(2-hydroxyethyl)-amine.The compounds of the formula I may also form inner salts.

Depending on the presence of asymmetric carbon atoms, the compounds ofthis invention may be in the form of mixtures of isomers, particularlyracemates, or in the form of pure isomers, particularly opticalantipodes.

Preferred are compounds of formula I, wherein R¹ and R³ are eachhydrogen and R² is hydrogen, phenyl optionally substituted ashereinbefore defined, especially hydrogen, or halogeno-phenyl, and mostespecially hydrogen or primarily 4-chlorophenyl or 4-fluorophenyl; orsalts, such as pharmaceutically acceptable salts thereof.

The present invention also provides a first process for the productionof compounds of formula I comprising, in a precursor compound of formulaII ##STR3## in which R¹, R² and R³ have their previous significance, Zis --NH₂ or a protected amino group Z^(o), Q is hydrogen or a protectinggroup Q^(o), and R^(c) is hydrogen, C₁ -₄ -alkyl, or an alkali metal orammonium cation, replacing the group R^(c), when it is alkyl, byhydrogen or by an alkali metal or ammonium cation, and replacing thegroup Q, when it is a protecting group Q^(o), by hydrogen, andconverting the group Z, when it is a protected amino group amino groupZ^(o), into --NH₂, to produce a compound of formula I.

Depending on the groups involved, the replacement and conversionoperations may be carried out in any sequence or simultaneously bymethods which are well-known per se.

If desired, a resulting salt may be converted into the free compound orinto another salt and/or, if desired, a resulting free compound may beconverted into a salt and/or, if desired, a resulting mixture of isomersmay be separated into the single isomers.

Typical protected amino groups Z^(o) are acylamino groups such asacetylamino, phthalimido, benzyloxycarbonylamino ortert-butoxycarbonylamino groups or 1-aryl-C₁ -₄ -alkylamino groups e.g.benzylamino.

Optional protecting groups Q^(o) are those known in the art anddescribed in EP 0 009 348 and Aust. J. Chem. 33, 292 (1980), e.g. groupshaving the formula --C(C₁ -₄ -alkyl)(OR^(a))OR^(b), in particular groupshaving the formula --CH(OR^(a))OR^(b) in which R^(a) and R^(b) are eachC₁ -₄ -alkyl and especially a group having the formula --CH(OC₂ H₅)₂.

The replacement of an alkyl group R^(c) in compounds of formula II byhydrogen may be effected by treatment with a suitable nucleophilicreagent such as an alkali metal hydroxide, e.g. sodium hydroxide, analkali metal halide, particularly bromide or iodide such as lithiumbromide or sodium iodide, thiourea, an alkali metal thiophenolate suchas sodium thiophenolate. The replacement reaction may be carried out inthe absence or presence of a solvent and, if necessary, while cooling orheating, in a closed vessel and/or under an atmosphere of an inert gas.

The replacement of the group Q^(o) and/or the group R^(c) in which R^(c)is C₁ -₄ -alkyl in compounds of formula II by hydrogen may be effectedby treatment with an acid under hydrolytic conditions, especially with amineral acid such as a hydrohalic acid e.g. hydrochloric acid which isused in dilute or concentrated aqueous form, or by treatment with anorganic silyl halide such as trimethyl-silyl iodide or bromide, followedby hydrolysis. The reaction is preferably conducted at elevatedtemperature e.g. while refluxing the reaction mixture and, if necessaryusing an organic diluent, in a closed vessel and/or under an atmosphereof an inert gas.

Protected amino group Z^(o) may be converted into free amino accordingto known methods, which are selected according to the characteristics ofthe protected amino group to be converted into amino, such as solvolyticor hydrogenolytic procedures, for example, hydrolysis in the presence ofan acid or a base, acidolysis, e.g. treatment with trifluoroacetic acid,treatment with hydrazine, or hydrogenolysis in the presence of ametallic hydrogenation catalyst, or any other suitable procedure,provided that the hydrogenation/catalyst method cannot be employed forcompounds of formula II wherein Q is hydrogen.

It is preferred that all protecting groups are converted, R^(c) andQ^(o) each being converted to H and Z^(o) being converted to NH₂, in asingle step, by treatment with an acid, preferably a hydrohalic acid,especially hydrochloric acid, under hydrolytic conditions.

The starting materials of formula II are new compounds, and form part ofthe present invention. Thus starting materials of formula II wherein R¹,R², R³, R^(c), Q and Z have their previous significance, provided that,when R² and Q are each hydrogen R^(c) may not be alkyl, are newcompounds and form part of this invention. The new compounds of formulaII may be prepared, for example, by various methods according to thenature of the group X in the formula IV defined hereinafter, byreacting, in the presence of a basic catalyst or in the presence ofagents forming free radicals, a compound of the formula III, ##STR4## inwhich R^(c) and Q have their previous significance, with a compound offormula IV, ##STR5## in which R¹ and R² have their previous significanceand X is a group capable of being converted into a group of formula Ia,##STR6## wherein R³ and Z have their previous significance, in order toproduce a compound of formula V, ##STR7## wherein R¹, R², R^(c), Q and Xhave their previous significance, and then converting the group X into agroup of formula Ia, to produce a compound of formula II.

A group X is primarily cyano but may also represent carbamoyl, a groupof formula Ib, ##STR8## in which R³ and Z^(o) have their previoussignificance; or X is a group of formula Ic, ##STR9## in which R³ hasits previous significance and ##STR10## is an optionally functionallymodified carbonyl group such as a corresponding ketal or thioketalgroup, including a corresponding cyclic group.

When, in a compound of formula III, Q is a protecting group Q^(o) andR^(c) is C₁ -₄ -alkyl and, in the compound of formula IV, X is anactivating group Xa such as cyano or ##STR11## then either a basiccatalyst or a free radical catalyst may be employed. When, however, thesame compounds of formula III are reacted with compounds of formula IVin which X is e.g. a residue of formula Ib, then free radical catalystsare required.

A basic catalyst used in the first step may be e.g. an alkali metal C₁-₄ -alkoxide, for example, a sodium or potassium C₁ -₄ -alkoxide, inparticular sodium methoxide, sodium ethoxide or potassium tert-butoxide,an alkaline or alkaline earth metal fluoride, such as potassium fluorideor caesium fluoride, or an alkali metal hydride, such as sodium hydride.The reaction may be effected with or without the use of an addedsolvent. If a solvent is added, this is preferably an alcohol, inparticular a C₁ -₄ -alkanol corresponding to the alkoxide used as basiccatalyst. The reaction temperature may vary from 0° C. to the boilingpoint of any added solvent.

Agents forming free radicals are, for example, ionizing and ultra-violetradiation, peroxy compounds, such as inorganic peroxy compounds, e.g.hydrogen peroxide or ammonium persulfate, or organic peroxides, e.g.benzoyl peroxide or tert-butyl peroxide, or organic azo compounds, e.g.azo-bis-isobutyronitrile. Reactions involving free radical-formingagents may be conducted in the optional presence of a solvent and, ifnecessary, while cooling or heating, in a closed vessel and/or in anatmosphere of an inert gas.

The conversion of a group X into the group Ia is carried out accordingto known methods. Cyano and carbamoyl are converted into aminomethyl byreduction, cyano, for example, by hydrogenation in the presence of asuitable catalyst, e.g. Raney nickel and of a solvent, such as ethanol,which may preferably contain ammonia, and carbamoyl, for example, bytreatment with a suitable hydride reducing agent, such as borane intetrahydrofuran, provided that the hydrogenation/catalyst method cannotbe employed for compounds of formula V in which Q is hydrogen.

Protected amino group Z^(o) may be converted into -NH₂ as describedhereinbefore.

The conversion of a group X in the compounds of formula V, in which X isa group Ic, in which Y is oxygen, into the group of the formula Ia iscarried out by known reductive amination procedures, e.g. treatment withsodium cyanoborohydride in the presence of ammonium acetate in asuitable solvent, such as dioxane, and while cooling, e.g. at about 0°C.

Compounds of formula III are either known or may be prepared by knownmethods viz. those described in Aust. J. Chem. 33, 292 (1980) or EP 0009 348.

Compounds of formula IV are either known or can be prepared by knownmethods.

Specific examples of compounds of formula III include:

methyl (dimethoxymethyl)phosphonite,

ethyl (dimethoxymethyl)phosphonite,

n-propyl (dimethoxymethyl)phosphonite,

i-propyl (dimethoxymethyl)phosphonite,

n-butyl (dimethoxymethyl)phosphonite

methyl (diethoxymethyl)phosphonite

n-propyl (diethoxymethyl)phosphonite,

n-butyl (diethoxymethyl)phosphonite

methyl (1,1-dimethoxyethyl)phosphonite

ethyl (1,1-dimethoxyethyl)phosphonite

ethyl (1,1-diethoxyethyl)phosphonite

methyl (1,1-dimethoxybutyl)phosphonite

preferred are methyl (dimethoxymethyl)phosphonite,

ethyl (diethoxymethyl)phosphonite,

methyl (1,1-dimethoxyethyl)phosphonite,

ethyl (1,1-diethoxyethyl)phosphonite

especially preferred is ethyl (diethoxymethyl)phosphonite.

The compounds of the formula V in which Q is Q^(o) particularly those,in which X is a cyano group or represents a group of the formula Ic, mayalso be prepared by reacting a compound of the formula VI, ##STR12## inwhich Q^(o) has its previous significance, R^(co) is C₁ -₄ -alkyl andeach R^(d) independently is C₁ -₆ -alkyl, preferably C₁ -₂ -alkylparticularly methyl, the groups R^(co) and R^(d) being the same ordifferent, with a compound of the formula VII, ##STR13## in which R¹ andR² have their previous significance and X has the previously givenmeaning, but is primarily cyano or a group of the formula Ic, and Halstands for halogeno, such as iodo, bromo or chloro. The reaction ispreferably carried out under the conditions of the Arbusov method, e.g.at a reaction temperature ranging from room temperature to an elevatedtemperature, e.g. 160° C., while removing the trialkyl silyl halideformed in the reaction.

Furthermore the compounds of formula V in which Q is Q^(o) and X is anactivating group Xa such as cyano or ##STR14## may be prepared byreacting a compound of formula VI, as defined above, with a compound offormula IV wherein R¹, R² and X have their previous significance. Thereaction is preferably conducted under the general conditions of theMichael addition reaction, e.g. at a temperature range between roomtemperature and 80° C., in the presence or, more likely, in the absenceof an inert solvent.

The silyl reagents of the formula VI are new and form part of thisinvention. Preferred compounds of formula VI are those having theformula VIA, ##STR15## wherein R^(a), R^(b), R^(co) and R^(d) have theirprevious significance and R⁴ is hydrogen or C₁ -₄ -alkyl, such as ethyltrimethylsilyl (diethoxymethyl)phosphonite, methyl trimethylsilyl(dimethoxymethyl)phosphonite, or ethyl trimethylsilyl(1,1-diethoxyethyl)phosphonite. The compounds of formula VI may beprepared by reaction, optionally in the presence of basic catalyst, of acompound having the formula III in which Q is Q^(o) and R^(c) is alkyl,viz. a compound having the formula IIIA ##STR16## in which Q^(o) andR^(co) have their previous significance; preferably a compound havingthe formula IIIB ##STR17## in which R^(co), R^(a) and R^(b) have theirprevious significance and R⁴ is hydrogen or C₁ -₄ -alkyl, with anappropriate silylating agent, e.g. trimethylsilyl chloride,dimethyl-tert-butyl-silyl chloride ordimethyl(2,3-dimethyl-2-butyl)silylchloride in the presence of atertiary base, e.g. pyridine or triethyl-amine, hexamethyl disilazane,1-trimethylsilyl-imidazole, or 1-(dimethyl-tert-butyl-silyl)-imidazole,or any other suitable silylating agent.

The process conditions employed vary depending on the particularsilylating agent used. The reaction temperature ranges from about -20°C. to about 150° C., and the reaction may be conducted with or withoutthe use of an inert solvent, such as e.g. diethyl ether, toluene,tetrahydrofuran or dioxan. Alternatively, an excess of the silylatingagent may be used as diluent. While the molar ratio of the silylatingagent to the compound of the formula IIIA or IIIB is conveniently 1:1,molar excess amounts of the silylating agent may be used to advantage incertain cases.

Compounds of formula VII are either known or may be prepared by knownmethods.

The compounds of formula I may also be prepared by, in a compound havingthe formula VIII, ##STR18## in which R¹, R² and X have their previoussignificance, converting the group X into a group of formula Id,##STR19## wherein R³ has its previous significance, to produce acompound of formula I.

The conversion of the group X into a group of formula Id may be effectedby any of the methods described hereinbefore in relation to theproduction of starting materials of formula II.

The above reaction is carried out according to known methods, in theabsence or presence of a solvent, which may also serve as a reagent, ifnecessary, while cooling or heating, in a closed vessel and/or in theatmosphere of an inert gas.

The starting materials of the formula VIII may be prepared, for example,from compounds of the formula V by converting the group R^(c) --O-- intohydroxy, the reaction being carried out according to the previouslydescribed procedure, e.g. by acidic hydrolysis, such as by treatmentwith an aqueous mineral acid, e.g. hydrochloric acid, or by treatmentwith a nucleophilic reagent and simultaneously or subsequentlyconverting any group Q which is Q^(o) into hydrogen.

Compounds of formula II in which R¹, R², R³ have their previoussignificance, R^(c) is R^(co) and Q is Q^(o) which has its previoussignificance may also be prepared by reducing a compound of formula IX##STR20## by known methods e.g. by catalytic hydrogenation.

Compounds of formula IX may be prepared by reacting a compound offormula X ##STR21## in the form of the anion XI, ##STR22## in which R¹,Q^(o) and R^(co) have their previous significance and M is an alkali ortransition metal atom, preferably lithium with a compound of formulaXII, ##STR23## in which R² and R³ have their previous significance.Compounds of formula XI may be prepared by reacting a compound offormula X with a base containing a metal atom M wherein M has itsprevious significance.

Compounds of formula IX and the process for their preparation are newand form part of this invention.

The base used in the first step may be e.g. a C₁ -₄ -alkyl lithium, a C₂-₄ -alkyl lithium amide or a metal amide, preferably lithiumdiisopropylamide. The reaction may be effected with the use of anaprotic solvent, preferably an ether, in particular tetrahydrofuran. Thereaction temperature may vary from -78° C. to room temperature, under anatmosphere of inert gas.

The compounds of formula X are known (EP 0 009 348) or may be preparedby known methods.

Compounds of formula XII are known and may be prepared by knownprocedures.

Compounds of formula V, ##STR24## wherein R^(c) and R² have theirprevious significance, Q is a protecting group Q^(o) wherein Q^(o) hasits previous significance, R¹ is hydrogen and X is an activating groupXa selected from groups X as hereinbefore defined and being a groupcapable of being converted into a group of formula Ia, --CH(R³)--Z,wherein R³ is H and Z has its previous significance, may also beprepared by reacting a compound of formula VA ##STR25## in the form ofthe anion VB ##STR26## wherein Q^(o), R^(co) and M, Xa have theirprevious significance with a compound of formula XIII

    LR.sup.2                                                   XIII

in which R² has its previous significance and L is a leaving group e.g.halogeno or tosyl. Said process as a means of introducing the group R²is of value merely if R² is different from hydrogen.

The starting materials of formula VA are known or may be preparedaccording to methods described for known compounds of formula Va forexample the methods described in European Patent Application EP 0 009348.

Depending on the process conditions used, the compounds of the formula Iare obtained in free form (Zwitterion) or in the form of their salts.The free compounds can be obtained from the salts in a manner known perse, the acid addition salts by treatment with suitable basic reagents,and the salts with bases by treatment with suitable acidic reagents.Acid addition salts can be obtained from the free compounds by reactionwith acids or anion exchange preparations, salts with bases by treatmentof the free compounds with bases or suitable cation exchange techniques.

The compounds, including their salts, can also be obtained in the formof their hydrates, or include other solvents used for thecrystallization.

Due to the close relationship between the new compounds in free form andin the form of their salts, hereinbefore and hereinafter the term "freecompounds" shall, if desired, also include the salts thereof, and theterm "salts" shall, if desired also include the free compounds, whereappropriate according to meaning and purpose. Mixtures of isomers ofcompounds of the formula I may be separated into the single isomersaccording to known methods. Racemates may be resolved, using knownclassical techniques, into individual optical antipodes, formingdiastereomeric salts, using e.g. optically active salt-forming acids,such as (+)- or (-)-tartaric acid or D-(+)-camphor sulfonic acid, oroptically active salt-forming bases, e.g. (+)- or(-)-α-methyl-benzylamine, separating the diastereomeric salts andliberating the desired free optical antipodes from the separated salts.

The invention relates also to those embodiments of the process, in whicha compound obtained as an intermediate at any stage of the process isused as starting material and the remaining process steps are carriedout, or in which a starting material is formed under the reactionconditions or is used in the form of a derivative, for example, a salt.

In the process of the present invention, the starting materials used arepreferably those that result in the compounds described at the beginningas especially valuable.

The compounds of this invention have been found to have very strongaffinities towards GABA_(B) receptor sites with inhibitoryconcentrations of 1 to 100 nmol/l. Activity of at least 20 times morepronounced than that of baclofen is observed with the compound ofexample 1. Agonists at the GABA_(B) receptor sites, in analogy tobaclofen, can be used as muscle relaxants in spinal spasticity, multiplesclerosis and cerebral palsy; in addition they are expected to be activein trigeminus neuralgia, in drug withdrawal syndroms, and as analgesics.Compounds combining GABA_(B) and GABA_(A) receptor agonist propertiesmay be active as antidepressants.

Antagonists on the other hand are expected to act as muscle stimulantsand to be active in muscular atrophy, dystrophy and weakness associatedfor example with Parkinsonism and Erb's paralysis. As GABA_(B) receptorantagonists are expected to increase glutamate and aspartate releaseduring neurotransmission, a positive effect in information processing inthe brain may be anticipated.

As a representative compound of the invention the compound of example 8has been shown to be active at the GABA_(B) receptor site with an IC₅₀-value of 35 nM, as a muscle relaxant (rotarod mice ID₅₀ -value of 6-9mg/kg i.p.), as an analgesic (phenylquinone writhing in mice ED₅₀ -valueof 4 mg/kg p.o.) and as an anticonvulsant (audiogenic seizures in DBA/2mice, ID₅₀ -value of 6 mg/kg i.p.). At a dose of 200 mg/kg i.p. nodeaths were observed.

Compounds of the invention depending on their pharmacological profilesare claimed to be active as muscle relaxants, muscle stimulants,analgesics, anticonvulsants, antidepressants, nootropics and drugsreducing drug withdrawal syndrome.

The aforementioned advantageous properties render the compounds of thisinvention of great value as specific therapeutic agents for mammalsincluding man.

The present invention relates also to pharmaceutical preparationscontaining compounds of the formula I or pharmaceutically acceptablesalts thereof. These preparations may be used especially in theabove-mentioned indications, if they are administered orally orparenterally, such as intravenously, intramuscularly or subcutaneously.The necessary dose depends on the particular disorder to be treated, itsseverity and the duration of therapy. The number and quantity of theindividual doses and also the administration scheme is best determinedon the basis of an individual examination of the host concerned, thesemethods being known to those skilled in the art. As a rule, however, atherapeutically active quantity of a compound of this invention is inthe dosage range of about 0.1 to 10 mg/kg body weight per day. Thepharmaceutical preparations are manufactured according to known methods,using standard auxiliary substances.

The following examples are intended to illustrate the invention and arenot to be construed as being limitations thereon. All parts wherevergiven are parts by weight. If not mentioned otherwise, all evaporationsunder reduced pressure are preferably performed between about 20 and 130mbar. The data designated as ³¹ P are phosphorus-31-NMR data.

EXAMPLE 1

a) A solution of 5.4 g of ethyl 3-aminopropyl(diethoxymethyl)phosphinate in 30 ml of 36% aqueous hydrochloric acid isheated to reflux under an atmosphere of nitrogen for a period of 3hours. The reaction mixture is then allowed to cool to room temperature,concentrated under reduced pressure and co-evaporated twice with 10 mlof water under reduced pressure. The crude product is dissolved in 50 mlof dry methanol, the solution is cooled to 0° C., and 5 ml of propyleneoxide is added dropwise. The mixture is concentrated under reducedpressure, triturated with 50 ml of ethanol and the crude product isfiltered off. Recrystallisation from a mixture of ethanol and methanolyields 3-aminopropyl-phosphonous acid, m.p. 209°-213° C., ³¹ P=+28.2 ppm(D₂ O).

b) The starting material can be prepared as follows:

A solution of 20 g of ethyl (diethoxymethyl)phosphonite (Aust. J. Chem.33, 292 (1980)) and 5 g of acrylonitrile in 25 ml of ethanol is added toa stirred mixture of 1 g of sodium hydride (50% dispersion in oil) in 25ml of ethanol at 0° C. under an atmosphere of nitrogen. The reactionmixture is allowed to warm to room temperature and stirred for 4 hours.1 ml of glacial acetic acid is added and the mixture is concentratedunder reduced pressure. The resulting crude product is dissolved in 50ml of ethyl acetate, washed twice with 26 ml of water, and the organicextract is dried over magnesium sulphate, and then concentrated underreduced pressure. The crude product is distilled under reduced pressureto give ethyl 2-cyanoethyl (diethoxymethyl)phosphinate, b.p. 114°C./0.01 mbar, ³¹ P=+40.8 ppm (CDCl₃).

This product can also be prepared as follows:

A solution of 10.6 g of ethyl (diethoxymethyl)phosphonite in 9 g ofhexamethyldisilazane is heated to reflux under an atmosphere of nitrogenfor a period of 3 hours. The reaction mixture is allowed to cool to 20°C. and then distilled under reduced pressure to give ethyltrimethylsilyl (diethoxymethyl)phosphonite, b.p. 51° C. at 0.01 mbar, ³¹P=+146.9 ppm (CDCl₃).

Reaction of ethyl trimethylsilyl(diethoxymethyl)phosphonite with3-chloropropionitrile yields ethyl2-cyanoethyl(diethoxymethyl)phosphinate, identical with the abovecompound.

A solution of 9.6 g of ethyl 2-cyanoethyl(diethoxymethyl)phosphinate in450 ml of ethanol is added to 82 g of an 8% solution of ammonia inethanol. To this is added 5 ml of Raney Nickel and the resulting mixtureis hydrogenated at 1 bar until the theoretical amount of hydrogen hasbeen taken up. The mixture is then filtered, the filtrate isconcentrated under reduced pressure and the crude product is distilledto give ethyl 3-aminopropyl(diethoxymethyl)phosphinate, b.p. 150°C./0.01 mbar, ³¹ P=+46.4 ppm (CDCl₃).

EXAMPLE 2

Further compounds, which are prepared according to the processhereinbefore described and illustrated in Example 1, are, for example,those of the following table:

    ______________________________________                                        R.sup.1    R.sup.2        R.sup.3                                             ______________________________________                                        a)   hydrogen  4-chlorophenyl hydrogen                                                                      (RS, R or S forms)                              b)   hydrogen  2-methylphenyl hydrogen                                        c)   hydrogen  4-bromophenyl  hydrogen                                        d)   hydrogen  2-methoxyphenyl                                                                              hydrogen                                        e)   hydrogen  3,4-dimethoxyphenyl                                                                          hydrogen                                        f)   hydrogen  4-trifluoromethyl-                                                                           hydrogen                                                       phenyl                                                         g)   hydrogen  3,4-dichlorophenyl                                                                           hydrogen                                        h)   hydrogen  sec-butyl      hydrogen                                        i)   hydrogen  n-octyl        hydrogen                                        j)   hydrogen  4-chlorobenzyl hydrogen                                        ______________________________________                                    

EXAMPLE 3

a) A solution of 14.1 g of ethyl3-amino-1-methylpropyl(diethoxymethyl)phosphinate in 50 ml of 36%aqueous hydrochloric acid is heated to reflux for a period of 5 hours.The reaction mixture is then allowed to cool to room temperature,concentrated under reduced pressure and co-evaporated twice with 20 mlof water under reduced pressure. The crude product is then dissolved in20 ml of water, washed twice with 20 ml of diethyl ether and the aqueouslayer is then separated and evaporated under reduced pressure. The crudeproduct is dissolved in 50 ml of dry ethanol and 5 ml of propylene oxideis added dropwise to produce an oily solid. This product is then passeddown an ion exchange resin column made from Dowex 50W-X2 and eluted withwater. Fractions showing a ninhydrin positive test are combined andevaporated under reduced pressure to give3-amino-1-methyl-propylphosphonous acid as a hygroscopic solid m.p.55°-60° C., ³¹ P=35.1 ppm (D₂ O).

b) The starting material may be prepared as follows:

A solution of 23.5 g of ethyl (diethoxymethyl)phosphonite and 6.7 g ofcrotononitrile in 30 ml of dry ethanol is added to a stirred mixture of1.2 g of sodium hydride (50% dispersion in oil) in 30 ml of ethanol at0° C. under an atmosphere of nitrogen. The reaction mixture is allowedto warm to room temperature and stirred for 4 hours. 1 ml of glacialacetic acid is added and the mixture concentrated under reducedpressure. The resulting crude product is dissolved in 50 ml of ethylacetate, washed twice with 25 ml of water, and the organic extract isdried over magnesium sulphate, and then concentrated under reducedpressure. The crude product is distilled under reduced pressure to giveethyl 2-cyano-1methylethyl(diethoxymethyl)phosphinate, b.p. 116° C./0.01mbar, ³¹ P=+42.2 and +42.0 ppm (CDCl₃).

A solution of 17.0 g of ethyl1-methyl-2-cyanoethyl(diethoxymethyl)phosphinate in 150 ml of ethanol isadded to 155.0 g of an 8% solution of ammonia in ethanol. To this areadded 10 ml of Raney Nickel and the resulting mixture is hydrogenated at1 bar until the theoretical amount of hydrogen has been taken up. Themixture is then filtered and the filtrate is concentrated under reducedpressure and the crude product is distilled under reduced pressure togive ethyl 3-amino-1-methylpropyl(diethoxymethyl)phosphinate, b.p. 140°C./0.01 mbar, ³¹ P=+47.0 and +46.7 ppm (CDCl₃).

EXAMPLE 4

a) A solution of 6.0 g of ethyl3-amino-2-methylpropyl(diethoxymethyl)phosphinate in 30 ml of 36%aqueous hydrochloric acid is heated to reflux for a period of 7 hours.The reaction mixture is then allowed to cool to room temperature,concentrated under reduced pressure and co-evaporated twice with 10 mlof water under reduced pressure. The crude product is dissolved in 50 mlof dry ethanol and 5 ml of propylene oxide is added dropwise. Theprecipitated solid is collected by filtration and dried to give3-amino-2-methylpropyl-phosphonous acid monohydrate, m.p. 96°-100° C.,³¹ P=+25.8 ppm (D₂ O).

b) The starting material may be prepared as follows:

A solution of 23.5 g of ethyl (diethoxymethyl)phosphonite and 6.7 g ofmethacrylonitrile in 30 ml of ethanol is added dropwise to a stirredmixture of 1.2 g of sodium hydride (50% dispersion in oil) in 30 ml ofethanol at 0° C. under an atmosphere of nitrogen. The reaction mixtureis allowed to warm to room temperature and stirred for 4 hours. 1 ml ofglacial acetic acid is added and the mixture is concentrated underreduced pressure. The resulting crude product is dissolved in 50 ml ofethyl acetate, washed twice with 25 ml of water, and the organic extractis dried over magnesium sulphate, and then concentrated under reducedpressure. The crude product is distilled under reduced pressure to giveethyl-2-cyanopropyl(diethoxymethyl)phosphinate, b.p. 116° C./0.01 mbar,³¹ P=+40.4 and +40.3 ppm (CDCl₃).

A solution of 17.0 g of ethyl 2-cyanopropyl(diethoxymethyl)phosphinatein 150 ml of ethanol is added to 155 g of an 8% solution of ammonia inethanol. To this are added 10 ml of Raney Nickel and the resultingmixture is hydrogenated at 1 bar until the theoretical amount ofhydrogen has been taken up. The mixture is then filtered, the filtrateis concentrated under reduced pressure and the crude product isdistilled under reduced pressure to give ethyl3-amino-2-methylpropyl(diethoxymethyl)phosphinate, b.p. 150° C./0.01mbar, ³¹ P=+45.8 and 45.7 ppm (CDCl₃).

EXAMPLE 5

a) A solution of 9.8 g of ethyl 3-aminobutyl(diethoxymethyl)phosphinatein 100 ml of 36% aqueous hydrochloric acid is heated to reflux for aperiod of 1 hour. The reaction mixture is then allowed to cool to roomtemperature, concentrated under reduced pressure and co-evaporated twicewith 10 ml of water under reduced pressure. The crude product is thendissolved in 20 ml of water, washed twice with 20 ml of diethyl etherand the aqueous layer is then separated and evaporated under reducedpressure. The crude product is passed down a column of Dowex 50W-X2eluted with water. Fractions showing a ninhydrin positive test arecombined and evaporated under reduced pressure to give3-aminobutylphosphonous acid (1/3M H₂ O), m.p. 195°-200° C., ³¹ P=+28.1ppm (D₂ O).

b) The starting material may be prepared as follows:

15.0 g of ethyl trimethylsilyl(diethoxymethyl)phosphonite are addeddropwise to a stirred solution of 3.9 g of methyl vinyl ketone under anatmosphere of nitrogen at room temperature. The mixture is then heatedto 50° C. for a period of 1 hour. The mixture is then allowed to cool toroom temperature, 25 ml of chloroform is then added followed by 10 mlwater and this mixture is vigorously stirred for a period of 0.5 h. Theorganic layer is then separated, dried over magnesium sulphate andconcentrated under reduced pressure and the crude product distilledunder reduced pressure to give ethyl3-oxobutyl(diethoxymethyl)phosphinate, b.p. 130°-135° C./0.02 mbar, ³¹P=+45.3 ppm (CDCl₃).

To a solution of 8.0 g of ethyl 3-oxobutyl(diethoxymethyl)phosphinate in100 ml of methanol is added 22.8 g of ammonium acetate and 1.3 g ofsodium cyanoborohydride. The mixture is stirred under an atmosphere ofnitrogen at room temperature for a period of 2.5 h, and then left tostand overnight. The mixture is then acidified to pH 2 with therequisite amount of dilute hydrochloric acid and the methanol isevaporated under reduced pressure. The crude product is dissolved in 25ml of water, washed twice with 20 ml of diethyl ether and the aqueousphase is then made alkaline to pH 12 with potassium hydroxide. Thesolution is then saturated with sodium chloride and extracted with 3×25ml of dichloromethane. The organic phase is dried over magnesiumsulphate, filtered and evaporated under reduced pressure and the crudeproduct distilled to give ethyl 3-aminobutyl(diethoxymethyl)phosphinate,b.p. 150° C./0.01 mbar, ³¹ P=+46.1 ppm (CDCl₃).

EXAMPLE 6

a) A solution of 17.9 g of ethyl3-amino-1-(4-chlorophenyl)propyl(diethoxymethyl)phosphinate in 200 ml of36% aqueous hydrochloric acid is heated to reflux for a period of 6hours. The reaction mixture is then allowed to cool to room temperature,concentrated under reduced pressure and co-evaporated twice with 50 mlof water under reduced pressure. The crude product is then dissolved in50 ml of water, washed twice with 20 ml of diethyl ether and the aqueouslayer is then separated and evaporated under reduced pressure. The crudeproduct is then dissolved in 50 ml of ethanol and 5 ml of propyleneoxide is added dropwise. The precipitated solid is collected byfiltration and dried to give 3-amino-1-(4-chlorophenyl)propylphosphonousacid, m.p. 210°-220° C., ³¹ P=+29.6 ppm (D₂ O).

b) The starting material may be prepared as follows:

A solution of 25.8 g of ethyl (diethoxymethyl)phosphonite and 18.0 g of4-chlorocinnamonitrile in 100 ml of ethanol is added to a stirredmixture of 1.2 g of sodium hydride (50% dispersion in oil) in 30 ml ofethanol at 0° C. under an atmosphere of nitrogen. The reaction mixtureis allowed to warm to room temperature and stirred for 4 hours. 1 ml ofglacial acetic acid is added and the mixture is concentrated underreduced pressure. The resulting crude product is dissolved in 50 ml ofethyl acetate, washed twice with 25 ml of water and the organic extractis dried over magnesium sulphate, and then concentrated under reducedpressure. The crude product is distilled under reduced pressure to giveethyl 1-(4-chlorophenyl)-2-cyanoethyl(diethoxymethyl)phosphinate, b.p.180°-200° C./0.02 mbar, ³¹ P=+37.9 and +37.8 ppm (CDCl₃).

A solution of 20 g of ethyl1-(4-chlorophenyl)-2-cyanoethyl(diethoxymethyl)phosphinate in 85 ml ofethanol is added to 131 g of an 8% solution of ammonia in ethanol. Tothis are added 8.5 ml of Raney Nickel and the resulting mixture ishydrogenated at 1 bar until the theoretical amount of hydrogen has beentaken up. The mixture is then filtered, the filtrate is concentratedunder reduced pressure and the crude product is distilled under reducedpressure to give ethyl3-amino-1-(4-chlorophenyl)propyl(diethoxymethyl)phosphinate, b.p. 190°C./0.02 mbar, ³¹ P=+41.5 and +41.3 ppm (CDCl₃).

EXAMPLE 7

a) A solution of 10.5 g of ethyl3-amino-3-(4-chlorophenyl)propyl(diethoxymethyl)phosphinate in 100 ml of36% aqueous hydrochloric acid is heated to reflux for a period of 2hours. The reaction mixture is then allowed to cool to room temperature,concentrated under reduced pressure, and co-evaporated twice with 25 mlof water under reduced pressure. The crude product is then dissolved in20 ml of water, washed twice with 20 ml of diethyl ether and the aqueouslayer is then separated and evaporated under reduced pressure. The crudeproduct is dissolved in 50 ml of ethanol and 5 ml of propylene oxide isadded dropwise. The precipitated solid is collected by filtration anddried to give 3-amino-3-(4-chlorophenyl)propylphosphonous acid, m.p.284°-286° C., ³¹ P=+27.2 ppm (D₂ O).

b) The starting material may be prepared as follows:

17.7 g of ethyl trimethylsilyl(diethoxymethyl)phosphonite is addeddropwise to a stirred solution of 11.7 g of 4-chlorophenyl vinyl ketoneunder an atmosphere of nitrogen, at room temperature. The reactionmixture is stirred for a period of 1 hour, 25 ml of chloroform is addedfollowed by 10 ml of water and this mixture is vigorously stirred for aperiod of 0.5 h. The organic layer is then separated, dried overmagnesium sulphate and concentrated under reduced pressure to give ethyl2-4-chlorobenzoyl-ethyl(diethoxymethyl)phosphinate as an oil, ³¹ P=+45.5ppm (CDCl₃).

To a solution of 25.4 g of ethyl2-(4-chlorobenzoyl)ethyl(diethoxymethyl)phosphinate in 200 ml ofmethanol is added 52 g of ammonium acetate and 4.23 g of sodiumcyanoborohydride. The mixture is stirred under an atmosphere of nitrogenat room temperature for a period of 3 days. The mixture is thenacidified to pH 2 with the requisite amount of dilute hydrochloric acidand the methanol is evaporated under reduced pressure. The crude productis dissolved in 25 ml of water, washed twice with 20 ml of diethyl etherand the aqueous layer is then made alkaline to pH 12 with potassiumhydroxide. The solution is then saturated with sodium chloride andextracted with 3×25 ml of dichloromethane. The organic phase is driedover magnesium sulphate and then evaporated under reduced pressure togive ethyl 3-amino-3-(4-chlorophenyl)propyl(diethoxymethyl)phosphinateas a viscous oil, ³¹ P=45.9 ppm (CDCl₃).

EXAMPLE 8

a) A solution of 5.0 g of ethyl3-amino-2-(4-chlorophenyl)propyl(diethoxymethyl)phosphinate in 60 ml of36% aqueous hydrochloric acid is heated to reflux for a period of 1 h.The reaction mixture is then allowed to cool to room temperature,concentrated under reduced pressure and co-evaporated twice with 20 mlof water under reduced pressure. The crude product is dissolved in 20 mlof water, washed twice with 20 ml of diethyl ether and the aqueous layeris then separated and evaporated under reduced pressure. The crudeproduct is dissolved in 50 ml ethanol and 5 ml of propylene oxide isadded dropwise. The precipitated solid is collected by filtration anddried to give 3-amino-2-(4-chlorophenyl)propylphosphonous acid (1/3M H₂O), m.p. 235°-240° C., ³¹ P=+23.9 ppm (D₂ O).

b) The starting material may be prepared as follows:

To a solution of 1.16 g of diisopropylamine in 40 ml of tetrahydrofuranat -78° C. under an atmosphere of nitrogen are added 7.2 ml of a 1.6Msolution of n-butyllithium in hexane. This solution is then stirred fora period of 10 minutes at this temperature, after which time a solutionof 2.0 g of ethyl (diethoxymethyl)methylphosphinate in 20 ml oftetrahydrofuran is added. This mixture is then stirred for a period of 1hour at -78° C. after which time a solution of 1.75 g of4-chloro-β-nitrostyrene in 20 ml of tetrahydrofuran is introduced. Thismixture is then allowed to warm to room temperature when 40 ml of asaturated ammonium chloride solution is added. The aqueous layer is thenextracted with 2×25 ml of diethyl ether and the organic extracts arecombined and dried over magnesium sulphate. The solvent is thenevaporated under reduced pressure and the crude product chromatographedon silica gel using ethyl acetate as an eluent to give ethyl2-(4-chlorophenyl)-3-nitropropyl(diethoxymethyl)phosphinate as a viscousoil, ³¹ P=+42.2 and +41.8 ppm (CDCl₃).

A solution of 8.0 g of ethyl2-(4-chlorophenyl)-3-nitropropyl(diethoxymethyl)phosphinate in 70 ml ofethanol is added to 64 g of an 8% solution of ammonia in ethanol. Tothis are added 8 ml of Raney Nickel and the resulting mixture ishydrogenated at 1 bar until the theoretical amount of hydrogen has beentaken up. The mixture is then filtered and the filtrate is concentratedunder reduced pressure to give ethyl3-amino-2-(4-chlorophenyl)propyl(diethoxymethyl) phosphinate as aviscous oil, ³¹ P=+44.2 and 44.1 ppm (CDCl₃).

EXAMPLE 9

a) A solution of 1.4 g of ethyl3-amino-2-cyclohexylpropyl(diethoxymethyl)phosphinate in 30 ml of 36%aqueous hydrochloric acid is heated to reflux for a period of 1 hour.The reaction mixture is then allowed to cool to room temperature,concentrated under reduced pressure and co-evaporated twice with 10 mlof water under reduced pressure. The crude product is then dissolved in20 ml of water washed twice with 20 ml of diethyl ether and the aqueouslayer is then separated and evaporated under reduced pressure. The crudeproduct is dissolved in 50 ml of dry ethanol and 5 ml of propylene oxideis added dropwise. The precipitated solid is collected by filtration anddried to give 3-amino-2-cyclohexylpropylphosphonous acid m.p. 235°-240°C., ³¹ P=28.2 ppm (D₂ O).

b) The starting material may be prepared as follows:

To a solution of 5.8 g of diisopropylamine in 40 ml of tetrahydrofuranat -78° C. under an atmosphere of nitrogen are added 35.7 ml of a 1.6Msolution of n-butyllithium in hexane. This solution is then stirred fora period of 10 minutes at this temperature, after which time a solutionof 10.0 g of ethyl (diethoxymethyl)methylphosphinate in 20 ml oftetrahydrofuran is added. This mixture is then stirred for a period of 1hour at -78° C. after which time a solution of 8.5 g of β-nitrostyrenein 20 ml of tetrahydrofuran is introduced. This mixture is then allowedto warm to room temperature when 40 ml of a saturated ammonium chloridesolution is added. The aqueous layer is then extracted with 2×25 ml ofdiethyl ether and the organic extracts are combined and dried overmagnesium sulphate. The solvent is then evaporated under reducedpressure and the crude product chromatographed on silica gel using ethylacetate as an eluent to give ethyl3-nitro-2-phenylpropyl(diethoxymethyl)phosphinate as a viscous oil, ³¹P=+42.3 and +42.0 ppm (CDCl₃).

A solution of 1.0 g of ethyl3-nitro-2-phenylpropyl(diethoxymethyl)phosphinate in 25 ml of ethanol isadded to 25 g of an 8% solution of ammonia in ethanol. To this are added0.5 ml of Raney Nickel and the resulting mixture hydrogenated at 1 baruntil the theoretical amount of hydrogen has been taken up. The mixtureis then filtered and the filtrate is concentrated under reduced pressureto give ethyl 3-amino-2-phenylpropyl(diethoxymethyl)phosphinate as aviscous oil, ³¹ P=+44.4 ppm (CDCl₃).

A solution of 3.45 g of ethyl3-amino-2-phenylpropyl(diethoxymethyl)phosphinate in 25 ml of tertiarybutanol is added to 2.0 g of 5% rhodium in alumina, suspended in 25 mlof tertiary butanol. The resulting mixture is hydrogenated at anatmosphere of 150 bar and temperature of 100° C. for a period of 20hours. The mixture is then filtered and the filtrate is concentratedunder reduced pressure. The crude product is chromatographed on silicagel using ethanol as eluent to give ethyl3-amino-2-cyclohexylpropyl(diethoxymethyl)phosphinate as a viscous oil,³¹ P=47.1 and +47.0 ppm (CDCl₃).

EXAMPLE 10

a) A solution of 3.5 g of ethyl3-amino-2-benzylpropyl(diethoxymethyl)phosphinate in 35 ml of 36%aqueous hydrochloric acid is heated to reflux for a period of 3 hours.The reaction mixture is then allowed to cool to room temperature,concentrated under reduced pressure and co-evaporated twice with 20 mlof water under reduced pressure. The crude product is dissolved in 20 mlof water, washed twice with 20 ml of diethyl ether and the aqueous layeris then separated and evaporated under reduced pressure. The crudeproduct is dissolved in 50 ml ethanol and 5 ml of propylene oxide isadded dropwise. The precipitated solid is collected by filtration anddried to give 3-amino-2-benzylpropylphosphonous acid, m.p. 205°-212° C.,³¹ P=+26.1 ppm (D₂ O).

b) The starting material may be prepared as follows:

To a solution of 0.97 g of diisopropylamine in 40 ml of tetrahydrofuranat -78° C. under an atmosphere of nitrogen are added 6.0 ml of a 1.6Msolution of n-butyllithium in hexane. This solution is then stirred fora period of 10 minutes at this temperature, after which time a solutionof 2.0 g of ethyl 2-cyanoethyl(diethoxymethyl)phosphinate in 10 ml oftetrahydrofuran is added. This mixture is then stirred for a period of 1hour at -78° C. after which time a solution of 1.4 g of benzyl bromidein 10 ml of tetrahydrofuran is introduced. This mixture is then allowedto warm to room temperature when 40 ml of a saturated ammonium chloridesolution is added. The aqueous layer is then extracted with 2×25 ml ofdiethyl ether and the organic extracts are combined and dried overmagnesium sulphate. The solvent is then evaporated under reducedpressure and the crude product chromatographed on silica gel using ethylacetate as an eluent to give ethyl2-benzyl-2-cyanoethyl(diethoxymethyl)phosphinate as a viscous oil, ³¹P=+40.7 and +40.5 ppm (CDCl₃).

A solution of 3.5 g of ethyl2-benzyl-2-cyanoethyl(diethoxymethyl)phosphinate in 50 ml of ethanol isadded to 25 g of an 8% solution of ammonia in ethanol. To this are added2 ml of Raney Nickel and the resulting mixture is hydrogenated at 1 baruntil the theoretical amount of hydrogen has been taken up. The mixtureis then filtered and the filtrate is concentrated under reduced pressureto give ethyl 3-amino-2-benzylpropyl(diethoxymethyl)phosphinate as aviscous oil, ³¹ P=+46.3 ppm (CDCl₃).

EXAMPLE 11

A solution of 5.0 g of ethyl3-amino-2-(4-chlorophenyl)propyl(diethoxymethyl)phosphinate in 60 ml of36% aqueous hydrochloric acid is heated to reflux for a period of 1hour. The reaction mixture is then allowed to cool to room temperature,concentrated under reduced pressure, and co-evaporated three times with20 ml of water under reduced pressure to give3-amino-2-(4-chlorophenyl)propylphosphonous acid hydrochloride, as ahygroscopic solid, ³¹ P=+30.1 ppm (D₂ O).

EXAMPLE 12

A solution of 0.25 g of 3-amino-2-(4-chlorophenyl)propylphosphonous acidin 10 ml of 0.1M sodium hydroxide solution is stirred at roomtemperature for a period of 1 hour, and then concentrated under reducedpressure to give sodium 3-amino-2-(4-chlorophenyl)propylphosphinate as ahygroscopic solid, ³¹ p=+26.0 ppm (D₂ O).

EXAMPLE 13

a) A solution of 4.0 g of ethyl3-amino-2-phenylpropyl(diethoxymethyl)phosphinate in 40 ml of 36%aqueous hydrochloric acid is heated to reflux for a period of 2 h. Thereaction mixture is then allowed to cool to room temperature,concentrated under reduced pressure and co-evaporated twice with 20 mlof water under reduced pressure. The crude product is dissolved in 20 mlof water, washed twice with 20 ml of diethyl ether and the aqueous layeris then separated and evaporated under reduced pressure. The crudeproduct is dissolved in 50 ml ethanol and 5 ml of propylene oxide isadded dropwise. The precipitated solid is collected by filtration anddried to give 3-amino-2-phenylpropylphosphonous acid m.p. 228°-235° C.,³¹ p=+24.3 ppm (D₂ O).

b) The starting material may be prepared as follows:

To a solution of 5.8 g of diisopropylamine in 40 ml of tetrahydrofuranat -78° C. under an atmosphere of nitrogen are added 35.7 ml of a 1.6Msolution of n-butyllithium in hexane. This solution is then stirred fora period of 10 minutes at this temperature, after which time a solutionof 10.0 g of ethyl (diethoxymethyl)methylphosphinate in 20 ml oftetrahydrofuran is added. This mixture is then stirred for a period of 1hour at -78° C. after which time a solution of 8.5 g of β-nitrostyrenein 20 ml of tetrahydrofuran is introduced. This mixture is then allowedto warm to room temperature when 40 ml of a saturated ammonium chloridesolution is added. The aqueous layer is then extracted with 2×25 ml ofdiethyl ether and the organic extracts are combined and dried overmagnesium sulphate. The solvent is then evaporated under reducedpressure and the crude product chromatographed on silica gel using ethylacetate as an eluent to give ethyl3-nitro-2-phenylpropyl(diethoxymethyl)phosphinate as a viscous oil, ³¹p=+42.4 and +42.0 ppm (CDCl₃).

A solution of 5.7 g of ethyl3-nitro-2-phenylpropyl(diethoxymethyl)phosphinate in 60 ml of ethanol isadded to 50 g of an 8% solution of ammonia in ethanol. To this are added9 ml of Raney Nickel and the resulting mixture is hydrogenated at 1 baruntil the theoretical amount of hydrogen has been taken up. The mixtureis then filtered and the filtrate is concentrated under reduced pressureto give ethyl 3-amino-2-phenylpropyl(diethoxymethyl)phosphinate as aviscous oil, ³¹ p=+44.4 ppm (CDCl₃).

EXAMPLE 14

a) A solution of 4.4 g of ethyl3-amino-2-(4-fluorophenyl)propyl(diethoxymethyl)phosphinate in 40 ml of36% aqueous hydrochloric acid is heated to reflux for a period of 2 h.The reaction mixture is then allowed to cool to room temperature,concentrated under reduced pressure and co-evaporated twice with 20 mlof water under reduced pressure. The crude product is dissolved in 20 mlof water, washed twice with 20 ml of diethyl ether and the aqueous layeris then separated and evaporated under reduced pressure. The crudeproduct is dissolved in 50 ml ethanol and 5 ml of propylene oxide isadded dropwise. The precipitated solid is collected by filtration anddried to give 3-amino-2-(4-fluorophenyl)propylphosphonous acid (1/3M H₂O), m.p. 225°-235° C., ³¹ p=+24.1 ppm (D₂ O).

b) The starting material may be prepared as follows:

To a solution of 5.8 g of diisopropylamine in 40 ml of tetrahydrofuranat -78° C. under an atmosphere of nitrogen are added 35.7 ml of a 1.6Msolution of n-butyllithium in hexane. This solution is then stirred fora period of 10 minutes at this temperature, after which time a solutionof 10.0 g of ethyl(diethoxymethyl)methylphosphinate in 20 ml oftetrahydrofuran is added. This mixture is then stirred for a period of 1hour at -78° C. after which time a solution of 7.96 g of4-fluoro-β-nitrostyrene in 20 ml of tetrahydrofuran is introduced. Thismixture is then allowed to warm to room temperature when 40 ml of asaturated ammonium chloride solution is added. The aqueous layer is thenextracted with 2×25 ml of diethyl ether and the organic extracts arecombined and dried over magnesium sulphate. The solvent is thenevaporated under reduced pressure and the crude product chromatographedon silica gel using ethyl acetate as an eluent to give ethyl2-(4-fluorophenyl)-3-nitropropyl(diethoxymethyl)phosphinate as a viscousoil, ³¹ p=+42.3 and +41.9 ppm (CDCl₃).

A solution of 5.0 g of ethyl2-(4-fluorophenyl)-3-nitropropyl(diethoxymethyl)phosphinate in 50 ml ofethanol is added to 40 g of an 8% solution of ammonia in ethanol. Tothis are added 7 ml of Raney Nickel and the resulting mixture ishydrogenated at 1 bar until the theoretical amount of hydrogen has beentaken up. The mixture is then filtered and the filtrate is concentratedunder reduced pressure to give ethyl3-amino-2-(4-fluorophenyl)propyl(diethoxymethyl)phosphinate as a viscousoil, ³¹ p=+44.4 ppm (CDCl₃).

EXAMPLE 15

a) A solution of 3.7 g of ethyl3-amino-2-(4-methylphenyl)propyl(diethoxymethyl)phosphinate in 40 ml of36% aqueous hydrochloric acid is heated to reflux for a period of 1 h.The reaction mixture is then allowed to cool to room temperature,concentrated under reduced pressure and co-evaporated twice with 20 mlof water under reduced pressure. The crude product is dissolved in 20 mlof water, washed twice with 20 ml of diethyl ether and the aqueous layeris then separated and evaporated under reduced pressure. The crudeproduct is dissolved in 50 ml ethanol and 5 ml of propylene oxide isadded dropwise. The precipitated solid is collected by filtration anddried to give 3-amino-2-(4-methylphenyl)propylphosphonous acid, m.p.250°-255° C., ³¹ p=+24.5 ppm (D₂ O).

b) The starting material may be prepared as follows:

To a solution of 8.7 g of diisopropylamine in 40 ml of tetrahydrofuranat -78° C. under an atmosphere of nitrogen are added 53.6 ml of a 1.6Msolution of n-butyllithium in hexane. This solution is then stirred fora period of 10 minutes at this temperature, after which time a solutionof 15.0 g of ethyl(diethoxymethyl)methylphosphinate in 20 ml oftetrahydrofuran is added. This mixture is then stirred for a period of 1hour at -78° C. after which time a solution of 11.6 g of4-methyl-β-nitrostyrene in 20 ml of tetrahydrofuran is introduced. Thismixture is then allowed to warm to room temperature when 40 ml of asaturated ammonium chloride solution is added. The aqueous layer is thenextracted with 2×25 ml of diethyl ether and the organic extracts arecombined and dried over magnesium sulphate. The solvent is thenevaporated under reduced pressure and the crude product chromatographedon silica gel using ethyl acetate as an eluent to give ethyl2-(4-methylphenyl)-3-nitropropyl(diethoxymethyl)phosphinate as a viscousoil, ³¹ p=+42.5 and +42.1 ppm (CDCl₃).

A solution of 6.5 g of ethyl2-(4-methylphenyl)-3-nitropropyl(diethoxymethyl)phosphinate in 60 ml ofethanol is added to 52 g of an 8% solution of ammonia in ethanol. Tothis are added 8 ml of Raney Nickel and the resulting mixture ishydrogenated at 1 bar until the theoretical amount of hydrogen has beentaken up. The mixture is then filtered and the filtrate is concentratedunder reduced pressure to give ethyl3-amino-2-(4-methylphenyl)propyl(diethoxymethyl)phosphinate as a viscousoil, ³¹ p=+44.6 ppm (CDCl₃).

EXAMPLE 16

a) A solution of 4.6 g of ethyl3-amino-2-(4-methoxyphenyl)propyl(diethoxymethyl)phosphinate in 30 ml of36% aqueous hydrochloric acid is heated to reflux for a period of 1hour. The reaction mixture is then allowed to cool to room temperature,concentrated under reduced pressure and co-evaporated twice with 20 mlof water under reduced pressure. The crude product is dissolved in 20 mlof water, washed twice with 20 ml of diethyl ether and the aqueous layeris then separated and evaporated under reduced pressure. The crudeproduct is dissolved in 50 ml ethanol and 5 ml of propylene oxide isadded dropwise. The precipitated solid is collected by filtration anddried to give 3-amino-2-(4-methoxyphenyl)propylphosphonous acid (1/2M H₂O), m.p. 260°-265° C., ³¹ p=+24.5 ppm (D₂ O).

b) The starting material may be prepared as follows:

To a solution of 8.7 g of diisopropylamine in 40 ml of tetrahydrofuranat -78° C. under an atmosphere of nitrogen are added 53.6 ml of a 1.6Msolution of n-butyllithium in hexane. This solution is then stirred fora period of 10 minutes at this temperature, after which time a solutionof 15.0 g of ethyl (diethoxymethyl)methylphosphinate in 20 ml oftetrahydrofuran is added. This mixture is then stirred for a period of 1hour at -78° C. after which time a solution of 12.8 g of4-methoxy-β-nitrostyrene in 20 ml of tetrahydrofuran is introduced. Thismixture is then allowed to warm to room temperature when 40 ml of asaturated ammonium chloride solution is added. The aqueous layer is thenextracted with 2×25 ml of diethyl ether and the organic extracts arecombined and dried over magnesium sulphate. The solvent is thenevaporated under reduced pressure and the crude product chromatographedon silica gel using ethyl acetate as an eluent to give ethyl2-(4-methoxyphenyl)-3-nitropropyl(diethoxymethyl)phosphinate as aviscous oil, ³¹ p=+42.4 and +42.1 ppm (CDCl₃).

A solution of 6.6 g of ethyl2-(4-methoxyphenyl)-3-nitropropyl(diethoxymethyl)phosphinate in 50 ml ofethanol is added to 52 g of an 8% solution of ammonia in ethanol. Tothis are added 8 ml of Raney Nickel and the resulting mixture ishydrogenated at 1 bar until the theoretical amount of hydrogen has beentaken up. The mixture is then filtered and the filtrate is concentratedunder reduced pressure to give ethyl3-amino-2-(4-methoxyphenyl)propyl(diethoxymethyl)phosphinate as aviscous oil, ³¹ p=+44.5 ppm (CDCl₃).

EXAMPLE 17

Preparation of 10,000 tablets each containing 10 mg of the activeingredient with a formula as follows:

    ______________________________________                                        3-aminopropylphosphonous acid                                                                         100.00 g                                              Lactose                 1,157.00 g                                            Corn starch             75.00 g                                               Polyethylene glycol 6,000                                                                             75.00 g                                               Magnesium stearate      18.00 g                                               Purified water          q.s.                                                  ______________________________________                                    

Procedure: All the powders are passed through a screen with openings of0.6 mm. Then the drug substance, lactose, magnesium stearate and half ofthe starch are mixed in a suitable mixer. The other half of the starchis suspended in 40 ml of water and the suspension added to the boilingsolution of the polyethylene glycol in 150 ml of water. The paste formedis added to the powders which are granulated, if necessary, with anadditional amount of water. The granulate is dried overnight at 35° C.,broken on a screen with 1,2 mm openings and compressed into tablets with6.4 mm diameter, uppers bisected.

EXAMPLE 18

Preparation of 10,000 capsules each containing 25 mg of the activeingredient with a formula as follows:

    ______________________________________                                        3-amino-2-(4-chlorophenyl)-                                                                         250.0 g                                                 propylphosphonous acid                                                        Lactose             1,750.0 g                                                 ______________________________________                                    

Procedure: All the powders are passed through a screen with openings of0.6 mm. Then the drug substance is placed in a suitable mixer and mixedwith the lactose until homogenous. No. 3 capsules are filled with 200 mgusing a capsule filling machine.

Similarly prepared are tablets and capsules comprising as activeingredients 10-100 mg of other compounds of the invention, e.g. thosegiven in the examples herein.

We claim:
 1. A compound of the formula II ##STR27## wherein R^(c) islower alkyl; one of the groups R¹, R² and R³ are hydrogen, C₁ -C₈-alkyl, C₃ -C₆ -cycloalkyl, phenyl optionally substituted by halogeno,C₁ -C₄ -alkyl, C₁ -C₄ -alkoxy and/or trifluoromethyl, or C₇ -C₁₀-phenylalkyl optionally substituted in the phenyl moiety by halogeno, C₁-C₄ -alkyl, C₁ -C₄ -alkoxy and/or trifluoromethyl, and the other two arehydrogen; Q is a group of the formula --CH(OR^(a))(OR^(b)) in whichR^(a) and R^(b) are each C₁ -C₄ -alkyl; and Z is --NH₂ or apharmaceutically acceptable salt thereof.
 2. Ethyl3-amino-1-(4-chlorophenyl)-propyl(diethoxymethyl)phosphinate accordingto claim
 1. 3. Ethyl3-amino-3-(4-chlorophenyl)-propyl(diethoxymethyl)phosphinate accordingto claim
 1. 4. Ethyl3-amino-2-(4-chlorophenyl)-propyl(diethoxymethyl)phosphinate accordingto claim
 1. 5. Ethyl3-amino-2-cyclohexyl-propyl(diethoxymethyl)phosphinate according toclaim
 1. 6. Ethyl 3-amino-2-benzyl-propyl(diethoxymethyl)phosphinateaccording to claim
 1. 7. Ethyl3-amino-2-phenyl-propyl(diethoxymethyl)phosphinate according to claim 1.8. Ethyl 3-amino-2-(4-fluorophenyl)-propyl(diethoxymethyl)phosphinateaccording to claim
 1. 9. Ethyl3-amino-2-(4-methylphenyl)-propyl(diethoxymethyl)phosphinate accordingto claim
 1. 10. Ethyl3-amino-2-(4-methoxyphenyl)-propyl(diethoxymethyl)phosphinate accordingto claim 1.